Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients
Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of soluble beta-1,3/1,6-glucan compared
to placebo on the healing of chronic leg ulcers in diabetes patients.
Hypothesis: Through its ability to activate tissue macrophages and counteract
diabetes-associated defects in macrophages, the soluble beta-1,3/1,6-glucan will promote the
healing of leg ulcers in diabetic patients.